Marshall Wace »

Eliem Therapeutics shares owned by Marshall Wace

Quarter-by-quarter ownership of Eliem Therapeutics (CLYM) shares owned by Marshall Wace from 13F filings

Historical chart of Marshall Wace investment in Eliem Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Eliem Therapeutics held by Marshall Wace consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Eliem Therapeutics by Marshall Wace

Quarter filed Position value Share count Share price at filing
2025-09-30 $462k 230k 2.01
2025-06-30 $46k 37k 1.24

More positions owned by Marshall Wace

Ishares-s&p 500 Etp (IVV)
Microsoft Corp Common Stock (MSFT)
Apple Common Stock (AAPL)
Nvidia Corp Common Stock (NVDA)
Amazon.com Common Stock (AMZN)
Meta Platforms-a Common Stock (META)
Circle Internet Common Stock (CRCL)
Boston Scientifc Common Stock (BSX)
Netflix Common Stock (NFLX)
Tesla Common Stock (TSLA)
Adv Micro Device Common Stock (AMD)
Market Vectors S Equity Option Call Option (SMH)
Walmart Common Stock (WMT)
Johnson&johnson Common Stock (JNJ)
Cencora Common Stock (COR)

View all positions for Marshall Wace

Top funds holding Eliem Therapeutics

RA Capital Management
Vanguard Group
Affinity Asset Advisors
Kynam Capital Management
Tang Capital Management
BlackRock
Peapod Lane Capital
Cantor Fitzgerald, L. P.
Renaissance Technologies
Deep Track Capital
Alyeska Investment Group
Millennium Management
Nan Fung Trinity
Sphera Funds Management
UBS Group

View all funds holding Eliem Therapeutics